Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Prevailing Burden Of Sepsis
3.1.2. Complications Arising Due To Hospital-Acquired Infections (Hais)
3.1.3. Spread Of Infectious Diseases Augmenting Sepsis Procedures
3.1.4. Surging Government Initiatives
3.2. Key Restraints
3.2.1. Complications Associated With The Reimbursement Policies
3.2.2. High Cost Of An Automated Diagnostics Instrument

4. Key Analytics
4.1. Impact Of Covid-19 On Sepsis Diagnostics Market
4.2. Key Investment Insights
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape

5. Market By Technology
5.1. Microbiology
5.2. Immunoassay
5.3. Molecular Diagnostics
5.4. Other Technologies

6. Market By Diagnostic Method
6.1. Conventional Diagnostics
6.2. Automated Diagnostics

7. Market By Product
7.1. Blood Culture Media
7.2. Assay Kits & Reagents
7.3. Instruments

8. Market By Pathogen
8.1. Gram - Positive And Gram - Negative Bacterial Sepsis
8.2. Fungal Sepsis
8.3. Other Pathogens

9. Market By Testing Type (In Terms Of Revenue: $ Million)
9.1. Laboratory Testing
9.2. Point-Of-Care Testing

10. Geographical Analysis
10.1. North America
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. United States
10.1.5.2. Canada

11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships, Contracts/Agreements & Collaborations
11.1.4. Business Expansions/ Approvals/ Announcements
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Becton, Dickinson And Company
11.2.3. Biomerieux Sa
11.2.4. Bruker Corporation
11.2.5. Cytosorbents
11.2.6. Danaher
11.2.7. Ekf Diagnostics
11.2.8. F. Hoffmann-La Roche
11.2.9. Immunexpress Inc
11.2.10. Luminex Corporation
11.2.11. Response Biomedical Corporation
11.2.12. T2 Biosystems Inc
11.2.13. Thermo Fisher Scientific Inc



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Sepsis Diagnostics Market, By Technology, In 2020
Figure 6: North America Sepsis Diagnostics Market, By Microbiology, 2021-2028 (In $ Million)
Figure 7: North America Sepsis Diagnostics Market, By Immunoassay, 2021-2028 (In $ Million)
Figure 8: North America Sepsis Diagnostics Market, By Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 9: North America Sepsis Diagnostics Market, By Other Technologies, 2021-2028 (In $ Million)
Figure 10: North America Sepsis Diagnostics Market, By Diagnostic Method, In 2020
Figure 11: North America Sepsis Diagnostics Market, By Conventional Diagnostics, 2021-2028 (In $ Million)
Figure 12: North America Sepsis Diagnostics Market, By Automated Diagnostics, 2021-2028 (In $ Million)
Figure 13: North America Sepsis Diagnostics Market, By Product, In 2020
Figure 14: North America Sepsis Diagnostics Market, By Blood Culture Media, 2021-2028 (In $ Million)
Figure 15: North America Sepsis Diagnostics Market, By Assay Kits & Reagents, 2021-2028 (In $ Million)
Figure 16: North America Sepsis Diagnostics Market, By Instruments, 2021-2028 (In $ Million)
Figure 17: North America Sepsis Diagnostics Market, By Pathogen, In 2020
Figure 18: North America Sepsis Diagnostics Market, By Gram - Positive And Gram - Negative Bacterial Sepsis, 2021-2028 (In $ Million)
Figure 19: North America Sepsis Diagnostics Market, By Fungal Sepsis, 2021-2028 (In $ Million)
Figure 20: North America Sepsis Diagnostics Market, By Other Pathogens, 2021-2028 (In $ Million)
Figure 21: North America Sepsis Diagnostics Market, By Testing Type, In 2020
Figure 22: North America Sepsis Diagnostics Market, By Laboratory Testing, 2021-2028 (In $ Million)
Figure 23: North America Sepsis Diagnostics Market, By Point-Of-Care Testing, 2021-2028 (In $ Million)
Figure 24: North America Sepsis Diagnostics Market, Country Outlook, 2020 & 2028 (In %)
Figure 25: United States Sepsis Diagnostics Market, 2021-2028 (In $ Million)
Figure 26: Canada Sepsis Diagnostics Market, 2021-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - SEPSIS DIAGNOSTICS
TABLE 2: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 11: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 12: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: LEADING PLAYERS OPERATING IN NORTH AMERICA SEPSIS DIAGNOSTICS MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES